Artículos de revistas sobre el tema "SJIA"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "SJIA".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Ombrello, Michael J., Victoria L. Arthur, Elaine F. Remmers, Anne Hinks, Ioanna Tachmazidou, Alexei A. Grom, Dirk Foell et al. "Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications". Annals of the Rheumatic Diseases 76, n.º 5 (7 de diciembre de 2016): 906–13. http://dx.doi.org/10.1136/annrheumdis-2016-210324.
Texto completoKim, Daeun, Jaeseung Song, Sora Lee, Junghyun Jung y Wonhee Jang. "An Integrative Transcriptomic Analysis of Systemic Juvenile Idiopathic Arthritis for Identifying Potential Genetic Markers and Drug Candidates". International Journal of Molecular Sciences 22, n.º 2 (12 de enero de 2021): 712. http://dx.doi.org/10.3390/ijms22020712.
Texto completoOmbrello, Michael J., Elaine F. Remmers, Ioanna Tachmazidou, Alexei Grom, Dirk Foell, Johannes-Peter Haas, Alberto Martini et al. "HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis". Proceedings of the National Academy of Sciences 112, n.º 52 (23 de noviembre de 2015): 15970–75. http://dx.doi.org/10.1073/pnas.1520779112.
Texto completoKaleda, M., E. Fedorov, I. Nikishina, S. Salugina, V. Matkava, M. Cherkasova y E. Samarkina. "AB1252 RETROSPECTIVE SINGLE CENTER STUDY OF THE PREDICTIVE ROLE OF CERTAIN BIOMARKERS IN MACROPHAGE ACTIVATION SYNDROME RELATED TO SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de mayo de 2022): 1736.2–1737. http://dx.doi.org/10.1136/annrheumdis-2022-eular.3328.
Texto completoRolfes, Elisabeth, Sae Lim von Stuckrad y Tilmann Kallinich. "Eine neue Lungenerkrankung bei Kindern mit systemischer JIA/Still-Syndrom". Kinder- und Jugendmedizin 21, n.º 05 (octubre de 2021): 358–63. http://dx.doi.org/10.1055/a-1558-7356.
Texto completoKrekhova, E. A., E. I. Alekseeva y T. M. Dvoryakovskaya. "Predictors of response to therapy with biologicals in children with systemic juvenile idiopathic arthritis". Voprosy praktičeskoj pediatrii 16, n.º 1 (2021): 64–78. http://dx.doi.org/10.20953/1817-7646-2021-1-64-78.
Texto completoVankova, D. D., E. I. Alekseeva, T. M. Dvoryakovskaya, R. V. Denisova, T. V. Radygina, I. V. Zubkova, E. A. Brzhozovskaya et al. "Activity of systemic juvenile idiopathic arthritis in children immunized with pneumococcal 13-valent conjugate vaccine: prospective cohort study". Voprosy praktičeskoj pediatrii 15, n.º 5 (2020): 40–50. http://dx.doi.org/10.20953/1817-7646-2020-5-40-50.
Texto completoZhou, Mi, Ruru Guo, Yong-Fei Wang, Wanling Yang, Rongxiu Li y Liangjing Lu. "Application of Weighted Gene Coexpression Network Analysis to Identify Key Modules and Hub Genes in Systemic Juvenile Idiopathic Arthritis". BioMed Research International 2021 (13 de agosto de 2021): 1–13. http://dx.doi.org/10.1155/2021/9957569.
Texto completoSun, Juan, Miao Feng, Fengqi Wu, Xiaolin Ma, Jie Lu, Min Kang y Zhewei Liu. "Plasma miR-26a as a Diagnostic Biomarker Regulates Cytokine Expression in Systemic Juvenile Idiopathic Arthritis". Journal of Rheumatology 43, n.º 8 (1 de junio de 2016): 1607–14. http://dx.doi.org/10.3899/jrheum.150593.
Texto completoGohar, Faekah, Angela McArdle, Melissa Jones, Niamh Callan, Belinda Hernandez, Christoph Kessel, Maria Miranda-Garcia et al. "Molecular signature characterisation of different inflammatory phenotypes of systemic juvenile idiopathic arthritis". Annals of the Rheumatic Diseases 78, n.º 8 (20 de abril de 2019): 1107–13. http://dx.doi.org/10.1136/annrheumdis-2019-215051.
Texto completoWeaver, L. K. "Combining multiple biomarkers differentiates between active SJIA, SJIA-MAS and EBV-HLH". Clinical & Experimental Immunology 191, n.º 3 (26 de octubre de 2017): 253–54. http://dx.doi.org/10.1111/cei.13063.
Texto completoGurion, R., T. J. A. Lehman y L. N. Moorthy. "Systemic Arthritis in Children: A Review of Clinical Presentation and Treatment". International Journal of Inflammation 2012 (2012): 1–16. http://dx.doi.org/10.1155/2012/271569.
Texto completoQuartier, Pierre. "Systemic Juvenile Idiopathic Arthritis/Pediatric Still’s Disease, a Syndrome but Several Clinical Forms: Recent Therapeutic Approaches". Journal of Clinical Medicine 11, n.º 5 (1 de marzo de 2022): 1357. http://dx.doi.org/10.3390/jcm11051357.
Texto completoDavidson, Nicole, Hemalatha G. Rangarajan, Kyla Driest, Rajinder P. S. Bajwa, Veronika Polishchuk y Rolla F. Abu-Arja. "Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome". Case Reports in Rheumatology 2021 (24 de mayo de 2021): 1–3. http://dx.doi.org/10.1155/2021/9323141.
Texto completoIshikawa, S., T. Mima, C. Aoki, N. Yoshio-Hoshino, Y. Adachi, T. Imagawa, M. Mori et al. "Abnormal expression of the genes involved in cytokine networks and mitochondrial function in systemic juvenile idiopathic arthritis identified by DNA microarray analysis". Annals of the Rheumatic Diseases 68, n.º 2 (3 de abril de 2008): 264–72. http://dx.doi.org/10.1136/ard.2007.079533.
Texto completoVillarreal, M. G., S. Bonaldi, L. Perez y M. Katsikas. "AB1007 SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: ARE DIFFERENT CLINICAL PATTERNS ASSOCIATED WITH S100A8/S100A9 SERUM LEVELS?" Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 1797.1–1797. http://dx.doi.org/10.1136/annrheumdis-2020-eular.5094.
Texto completoRossi-Semerano, Linda y Isabelle Koné-Paut. "Is Still's Disease an Autoinflammatory Syndrome?" International Journal of Inflammation 2012 (2012): 1–5. http://dx.doi.org/10.1155/2012/480373.
Texto completoMacaubas, Claudia, Khoa Nguyen, Ariana Peck, Elizabeth Wong, Julia Buckingham, Yael Goertz, Chetan Deshpande et al. "Monocyte phenotypes in systemic juvenile idiopathic arthritis (44.13)". Journal of Immunology 186, n.º 1_Supplement (1 de abril de 2011): 44.13. http://dx.doi.org/10.4049/jimmunol.186.supp.44.13.
Texto completoMinoia, Francesca, Francesca Bovis, Sergio Davì, AnnaCarin Horne, Michel Fischbach, Michael Frosch, Adam Huber et al. "Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis". Annals of the Rheumatic Diseases 78, n.º 10 (11 de julio de 2019): 1357–62. http://dx.doi.org/10.1136/annrheumdis-2019-215211.
Texto completoAlekseeva, Ekaterina I., Dariya D. Van’kova, Margarita A. Soloshenko, Tatyana M. Dvoryakovskaya, Kseniya B. Isaeva, Rina V. Denisova, Anna V. Mamutova, Aleksandra M. Chomahidze, Nikolay A. Mayanskiy y Natalya E. Tkachenko. "Pneumococcal Vaccine in Patients with Systemic Juvenile Idiopathic Arthritis Receiving Biologic Therapy: International Practice Review". Current Pediatrics 18, n.º 2 (23 de junio de 2019): 101–8. http://dx.doi.org/10.15690/vsp.v18i2.2012.
Texto completoPetrongari, Duilio, Paola Di Filippo, Francesco Misticoni, Giulia Basile, Sabrina Di Pillo, Francesco Chiarelli y Marina Attanasi. "Lung Involvement in Systemic Juvenile Idiopathic Arthritis: A Narrative Review". Diagnostics 12, n.º 12 (8 de diciembre de 2022): 3095. http://dx.doi.org/10.3390/diagnostics12123095.
Texto completoSaper, Vivian E., Guangbo Chen, Gail H. Deutsch, R. Paul Guillerman, Johannes Birgmeier, Karthik Jagadeesh, Scott Canna et al. "Emergent high fatality lung disease in systemic juvenile arthritis". Annals of the Rheumatic Diseases 78, n.º 12 (27 de septiembre de 2019): 1722–31. http://dx.doi.org/10.1136/annrheumdis-2019-216040.
Texto completoAilioaie, Laura Marinela, Constantin Ailioaie y Gerhard Litscher. "Biomarkers in Systemic Juvenile Idiopathic Arthritis, Macrophage Activation Syndrome and Their Importance in COVID Era". International Journal of Molecular Sciences 23, n.º 21 (22 de octubre de 2022): 12757. http://dx.doi.org/10.3390/ijms232112757.
Texto completoKaleda, M., I. Nikishina, V. Matkava, A. Shapovalenko, E. Fedorov y S. Salugina. "AB0725 MACROPHAGE ACTIVATION SYNDROME IN CHILDREN WITH RHEUMATIC DISEASES: ANALYSIS OF CASE SERIES". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de mayo de 2021): 1393.3–1394. http://dx.doi.org/10.1136/annrheumdis-2021-eular.2098.
Texto completoAlekseeva, E., R. Denisova, S. Valieva, T. Bzarova, T. Sleptsova, E. Mitenko y K. Isayeva. "P02-029 - CAPS or SJIA". Pediatric Rheumatology 11, Suppl 1 (2013): A136. http://dx.doi.org/10.1186/1546-0096-11-s1-a136.
Texto completoKathmann, Wiebke. "Hoffnung für Patienten mit SJIA". pädiatrie hautnah 25, n.º 2 (21 de marzo de 2013): 117. http://dx.doi.org/10.1007/s15014-013-0071-z.
Texto completoKostik, Mikhail Mikhaylovich, Tatyana Serafimovna Likhacheva, Irina Aleksandrovna Chikova, Natal’ya Valer’yevna Buchinskaya, Natal’ya Nikolaevna Abramova, Olga Valeryevna Kalashnikova, Randy Q. Cron y Vyacheslav Grigoryevich Chasnyk. "Higher-dose canakinumab therapy for refractory macrophage activation syndrome in children with systemic juvenile idiopathic arthritis: two case reports". Pediatrician (St. Petersburg) 5, n.º 4 (15 de diciembre de 2014): 14–19. http://dx.doi.org/10.17816/ped5414-19.
Texto completoLee, Pui Y., Grant S. Schulert, Scott W. Canna, Yuelong Huang, Jacob Sundel, Ying Li, Kacie J. Hoyt et al. "Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis". Annals of the Rheumatic Diseases 79, n.º 2 (9 de noviembre de 2019): 225–31. http://dx.doi.org/10.1136/annrheumdis-2019-216030.
Texto completoRoth, Johannes. "Komplizierter Verlauf einer systemischen JIA". Arthritis und Rheuma 42, n.º 02 (abril de 2022): 114–19. http://dx.doi.org/10.1055/a-1781-8225.
Texto completoCanny, Susan y Elizabeth Mellins. "New frontiers in the treatment of systemic juvenile idiopathic arthritis". F1000Research 6 (22 de junio de 2017): 971. http://dx.doi.org/10.12688/f1000research.11327.1.
Texto completoKrekhova, E., E. Alexeeva, T. Dvoryakovskaya, K. Isaeva, R. Denisova, O. Lomakina, A. Mamutova et al. "POS1312 DRUG SURVIVAL FOR IL-6 INHIBITOR TOCILIZUMAB: DATA FROM A SINGLE-CENTER OBSERVATION". Annals of the Rheumatic Diseases 80, Suppl 1 (19 de mayo de 2021): 938–39. http://dx.doi.org/10.1136/annrheumdis-2021-eular.2255.
Texto completoAlexeeva, Ekaterina I., Dariya D. Vankova, Tatyana M. Dvoryakovskaya, Ksenia B. Isaeva, Rina V. Denisova, Anna V. Mamutova, Aleksandra M. Chomakhidze et al. "Efficacy of Pneumococcal Polysaccharide Conjugate Vaccine (13-valent, Adsorbed) in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Genetically Engineered Biologic Drugs (Tocilizumab or Canakinumab): Prospective Cohort Study". Current Pediatrics 19, n.º 3 (10 de agosto de 2020): 190–99. http://dx.doi.org/10.15690/vsp.v19i3.2114.
Texto completoWorley, Emily, Weijie Li y Jordan T. Jones. "Atypical Presentation of Systemic Arthritis in a Toddler with Down Syndrome". Case Reports in Pediatrics 2021 (11 de agosto de 2021): 1–4. http://dx.doi.org/10.1155/2021/6567770.
Texto completoCepika, Alma-Martina, Romain Banchereau, Elodie Segura, Marina Ohouo, Brandi Cantarel, Kristina Goller, Victoria Cantrell et al. "A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis". Journal of Experimental Medicine 214, n.º 11 (21 de septiembre de 2017): 3449–66. http://dx.doi.org/10.1084/jem.20170412.
Texto completoGorelik, Mark, Ndate Fall, Mekibib Altaye, Michael G. Barnes, Susan D. Thompson, Alexei A. Grom y Raphael Hirsch. "Follistatin-like Protein 1 and the Ferritin/Erythrocyte Sedimentation Rate Ratio Are Potential Biomarkers for Dysregulated Gene Expression and Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis". Journal of Rheumatology 40, n.º 7 (15 de mayo de 2013): 1191–99. http://dx.doi.org/10.3899/jrheum.121131.
Texto completode Zegher, Francis, Nele Reynaert, Lien De Somer, Carine Wouters y Mathieu Roelants. "Growth Failure in Children with Systemic Juvenile Idiopathic Arthritis and Prolonged Inflammation despite Treatment with Biologicals: Late Normalization of Height by Combined Hormonal Therapies". Hormone Research in Paediatrics 90, n.º 5 (2018): 337–43. http://dx.doi.org/10.1159/000489778.
Texto completoYasin, Shima, Ndate Fall, Rachel A. Brown, Maggie Henderlight, Scott W. Canna, Charlotte Girard-Guyonvarc’h, Cem Gabay, Alexei A. Grom y Grant S. Schulert. "IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome". Rheumatology 59, n.º 2 (20 de julio de 2019): 361–66. http://dx.doi.org/10.1093/rheumatology/kez282.
Texto completoAlexeeva, E., E. Krekhova, T. Dvoryakovskaya, K. Isaeva, A. Chomakhidze, E. Chistyakova, O. Lomakina et al. "THU0506 LONG-TERM EFFECTIVENESS AND SAFETY OF CANAKINUMAB AS A SECOND BIOLOGIC AFTER TOCILIZUMAB IN CHILDREN WITH EARLY AND LATE JIA WITH ACTIVE SYSTEMIC FEATURES". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 491.2–492. http://dx.doi.org/10.1136/annrheumdis-2020-eular.5706.
Texto completoPardeo, Manuela, Jianmei Wang, Nicolino Ruperto, Ekaterina Alexeeva, Vyacheslav Chasnyk, Rayfel Schneider, Gerd Horneff et al. "Neutropenia During Tocilizumab Treatment Is Not Associated with Infection Risk in Systemic or Polyarticular-course Juvenile Idiopathic Arthritis". Journal of Rheumatology 46, n.º 9 (1 de marzo de 2019): 1117–26. http://dx.doi.org/10.3899/jrheum.180795.
Texto completoR, N., A. Jain, H. Muhammed, A. Aggarwal, V. Agarwal, L. Gupta, D. Misra, A. Lawrence y R. Misra. "SAT0230 MACROPHAGE ACTIVATION SYNDROME IN SLE AND SYSTEMIC ONSET JIA: SIMILAR OR DISSIMILAR". Annals of the Rheumatic Diseases 79, Suppl 1 (junio de 2020): 1057.2–1058. http://dx.doi.org/10.1136/annrheumdis-2020-eular.4469.
Texto completoBatulevičiūtė, Lina, Violeta Radžiūnienė, Ramunė Vankevičienė, Odeta Kinčinienė y Violeta Panavienė. "VAIKŲ NEAIŠKIOS KILMĖS KARŠČIAVIMAS". Medicinos teorija ir praktika 20, n.º 4 (20 de febrero de 2014): 376–81. http://dx.doi.org/10.15591/mtp.2014.067.
Texto completoRUSSO, RICARDO A. G. y MARÍA M. KATSICAS. "Patients with Very Early-onset Systemic Juvenile Idiopathic Arthritis Exhibit More Inflammatory Features and a Worse Outcome". Journal of Rheumatology 40, n.º 3 (15 de enero de 2013): 329–34. http://dx.doi.org/10.3899/jrheum.120386.
Texto completoBracaglia, Claudia, Kathy de Graaf, Denise Pires Marafon, Florence Guilhot, Walter Ferlin, Giusi Prencipe, Ivan Caiello et al. "Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis". Annals of the Rheumatic Diseases 76, n.º 1 (13 de junio de 2016): 166–72. http://dx.doi.org/10.1136/annrheumdis-2015-209020.
Texto completoZimmermann, Wolfgang. "Dauerhafte Symptomreduktion bei CAPS und sJIA". pädiatrie: Kinder- und Jugendmedizin hautnah 28, n.º 1 (febrero de 2016): 66. http://dx.doi.org/10.1007/s15014-016-0637-7.
Texto completoOnuora, Sarah. "Multi-pronged approach uncovers sJIA mechanisms". Nature Reviews Rheumatology 13, n.º 11 (12 de octubre de 2017): 631. http://dx.doi.org/10.1038/nrrheum.2017.173.
Texto completoKriulin, I. A., E. I. Alexeeva, I. Yu Shilkrot y T. M. Dvoryakovskaya. "Secondary hemophagocytic lymphohistiocytosis: prognostic model and early markers in patients with systemic juvenile idiopathic arthritis. Results of a cohort retrospective study". Voprosy praktičeskoj pediatrii 17, n.º 6 (2022): 17–24. http://dx.doi.org/10.20953/1817-7646-2022-6-17-24.
Texto completoKaleda, M. I., I. P. Nikishina, S. O. Salugina, E. S. Fedorov y E. V. Nikolaeva. "MACROPHAGE ACTIVATION SYNDROME IN RHEUMATIC DISEASES IN CHILDREN: A RETROSPECTIVE STUDY". Pediatria. Journal named after G.N. Speransky 100, n.º 5 (11 de octubre de 2021): 53–61. http://dx.doi.org/10.24110/0031-403x-2021-100-5-53-61.
Texto completoLimenis, Elizaveta, Brian M. Feldman, Camille Achonu, Michelle Batthish, Bianca Lang, Marjorie Mclimont, Sylvia Ota et al. "Proposed Core Set of Items for Measuring Disease Activity in Systemic Juvenile Idiopathic Arthritis". Journal of Rheumatology 45, n.º 1 (1 de agosto de 2017): 115–21. http://dx.doi.org/10.3899/jrheum.161534.
Texto completoTajkia, Gule, Syed Khairul Amin, Shamim Rima, Soma Halder y Fabia Hannan. "Systemic Onset Juvenile Idiopathic Arthritis (sJIA) or Still's Disease: A Diagnostic Challenge; while Presented as Fever of Unknown Origin. 2 Cases". Anwer Khan Modern Medical College Journal 10, n.º 1 (20 de octubre de 2019): 84–88. http://dx.doi.org/10.3329/akmmcj.v10i1.43667.
Texto completoKirchner, M., B. Robinson, L. Strothmann, A. Sonnenschein y W. Mannhardt-Laakmann. "In-vitro-Einfluss von Adalimumab und Anakinra auf das Zytokin-netzwerk bei Patienten mit oJIA und sJIA". Arthritis und Rheuma 35, n.º 05 (2015): 323–30. http://dx.doi.org/10.1055/s-0037-1618388.
Texto completo